FLORBETABEN F-18
| Brand name | NEURACEQ |
|---|---|
| Active ingredient | FLORBETABEN F-18 |
| Strength | 1.4-135mCi/ML |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | March 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9308284 | July 2032 | product |
| 7807135 | March 2029 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.